Protagen Oncimmune Buys Protagen for £4.1M The company said that it plans to use Protagen's assets to further the development and commercialization of its EarlyCDT cancer diagnostics. Protagen, NCT Heidelberg Partner to Predict Immunotherapy Response in Urothelial Cancer The project aims to identify biomarkers for predicting response and adverse events in urothelial carcinoma patients receiving immunotherapy. Protagen, NCT, NEC Partner on Prediction of Immunotherapy Response in Melanoma The parties will use machine learning to develop biomarker models for immunotherapy endpoints, including adverse effects, clinical response, and survival. Protagen Shifting to Focus on Cancer Immunotherapy Premium With a series of recent collaborations in hand, the company is leveraging its experience in autoimmune biomarkers to move into the immunoncology space. Protagen, Gustave Roussy Collaborating on Markers for Immunotherapy Side Effects Under the collaboration, they will use Protagen's SeroTag platform to test cancer immunotherapy patients for markers linked to immune-related adverse events. Feb 2, 2017 Protagen, NCI Partner to Identify Cancer Immunotherapy Biomarkers Jan 20, 2017 Immunovia's Blood-Based Array Test for Lupus Advances in New Study Premium Jan 17, 2017 Protagen, German Cancer Center Collaborate on Immunotherapy Biomarkers Aug 11, 2016 Protagen Licenses Systemic Sclerosis Marker to Inova Jun 15, 2016 Protagen Receives CE Mark for BICD2 Systemic Sclerosis Marker Mar 4, 2016 Protagen Using Protein Array Tech for Drug Target ID; Will Release Autoimmune Marker Panels Premium Feb 12, 2016 Researchers From Protagen, Targos, Elsewhere ID Protein Biomarkers for Prostate Inflammation Dec 11, 2015 Protagen Working With MATURA Consortium to Develop Proteomic Test to Predict Drug Response in RA Premium Nov 12, 2015 Protagen, Mikrogen Ink Lyme Disease Diagnostic Deal Jun 24, 2015 Protagen Obtains ISO Certification Dec 16, 2014 Protagen Closes First Part of Financing Round Nov 21, 2014 Qiagen Makes Move toward Proteomics with Protagen CDx Development Deal Premium Nov 17, 2014 Protagen, Qiagen Collaborate to Advance Development of Protein-based CDx for Autoimmune Diseases Sep 5, 2014 New Products: Biognosys, Protagen Premium Dec 3, 2013 Protagen Signs Biomarker Discovery Deal with Pfizer Jul 2, 2013 Protagen Sells Protein Services Subsidiary in Shift Toward Focus on Dx Development Mar 16, 2012 Protagen and NMI Collaborating on Protein Dx for Cancer and Autoimmune Diseases Premium Mar 16, 2012 Protagen, NMI Developing Assays for Autoimmune Diseases, Cancer Dec 7, 2011 Protagen, Bayer Partner on Biomarkers for Endometriosis Oct 28, 2011 Protagen, Charles River Ink Protein Analysis Services Alliance Load More Breaking News SUPER Psychosis Study Presented at ASHG Digs Into Relationships of Rare Variants, Phenotypes People in the News: New Appointments at Myriad Genetics, Becton Dickinson, Delfi Diagnostics, More In Brief This Week: Virginia Commonwealth University, Dovetail Genomics, Lucid Diagnostics, and More New Products Posted to GenomeWeb: Bio-Rad, PerkinElmer, Ares Genetics, Purigen Biosystems, More Genetron Health, Fosun Ink Commercialization Deal for Seq-MRD Test in China MultiMuTHER Team Tracks Expression, Metabolite Relationships in Aging TwinsUK Participants The Scan More Boosters for US Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes. From a Pig A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports. For Privacy's Sake Wired reports that more US states are passing genetic privacy laws. Science Paper on How Poaching Drove Evolution in African Elephants In Science this week: poaching has led to the rapid evolution of tuskless African elephants.